BU-NOT-SET

CONTACT US
Guidance for start-ups on drug development
  • Drug product
Eyes
Insight
Drug development for start-ups
  • Drug product
  • Drug substance
Test tubes
White paper
Optimising environmental sustainability
  • Sustainability
Eyes
Insight
Adapting to deal with the COVID-19 pandemic
  • Industry trends
Eyes
Insight
On Drug Delivery – Sustainability Q&A
  • Sustainability
Eyes
Insight
Optimising analytical chemistry to improve speed to market
  • Analytical chemistry
Man lab
Insight
The Recipharm Journey
  • Corporate
Eyes
Insight
Solubility enhancement
  • Drug substance
Man holding liquid container
Fact sheet
Unlocking the key changes to Annex 1
  • Manufacturing
Eyes
Insight
Insight
  • Manufacturing
When OSD manufacturing goes global
Insight
  • Drug product
  • Manufacturing
Ensuring Reliable HPAPI Supply
Insight
  • Drug product
  • Manufacturing
De-risking high-potency programmes
Case study
  • Analytical chemistry
  • Drug product
Analytical method development for multivitamin tablets
Insight
  • Drug product
  • Manufacturing
The evolving OSD market: Complexity, capability and collaboration
Insight
  • Drug product
  • Manufacturing
High-potency APIs and the evolving demands of drug development
White paper
  • Drug product
  • Manufacturing
Safely scaling high potency API manufacturing
Insight
  • Drug product
  • Manufacturing
From development insight to manufacturing confidence
Insight
  • Biologics
  • Manufacturing
Recipharm Advanced Bio Is Advancing RNA Therapeutics